McDonald's reports better-than-expected earnings thanks to improved operating measures and rising sales. » Read More
U.S. biotechnology company Celgene reported a 21 percent jump in quarterly revenue, driven by demand for its key multiple myeloma drug, Revlimid.
Harley-Davidson reported a lower quarterly net income on Thursday as soft demand slowed sales in the United States, the company's biggest market.
Facebook posted quarterly earnings and revenue that blew away analyst estimates as its ad business flourished.
Facebook's average revenue per user stood at $3.82 for the most recent quarter, much higher than the previous period. Mark Zuckerberg can thank mobile ads.
European oil majors Royal Dutch Shell and Total reported a sharp decline in profits in the second-quarter of 2016, as the low oil price continued to weigh on earnings.
Whole Foods reported quarterly earnings and revenue that met analysts expectations on Wednesday.
CNBC's Josh Lipton reports GoPro's Q2 earnings.
France's biggest bank, BNP Paribas, posted a narrow increase in net profit on Thursday, as its retail bank struggled to the low interest-rate environment.
Comcast chief Brian Roberts says "our momentum continues across our businesses."
Coca-Cola share prices fall after the Dow component cut its organic revenue forecast for the year.
Boeing reported its first quarterly loss in nearly seven years, hit by charges related to the 787, 747 and KC-46 tanker aircraft programs.
Fiat Chrysler Automobiles reported a 14 percent drop in operating profit after charges related to recall costs and capacity shifts in North America.
Mondelez's quarterly net revenue fell nearly 18 percent, as a strong dollar eroded the value of sales from markets outside the U.S.
Lumber Liquidators' quarterly sales fell for the fifth straight quarter as the company struggles to convince customers its hardwood flooring is safe.
Apple reported quarterly earnings and revenue that topped analyst expectations on Tuesday, as its bet on the iPhone SE paid off.
Bayer surpassed second-quarter earnings expectations and raised its guidance for the year on strong gains in stroke prevention pill Xarelto.
Get the best of CNBC in your inbox